The Precision Peptide Genetic Test may provide context about your predisposition in GLP1R and metabolic pathways, which can inform discussions about GLP-1 for metabolic or weight goals
"Orforglipron, an oral small-molecule GLP-1 receptor agonist, for the treatment of obesity in people with type 2 diabetes (ATTAIN-2): a phase 3, double-blind, randomised, multicentre, placebo-controlled trial"
*Deposits will be sent after booking alongside a consent form via our 3rd party app
We continuously improve our services to ensure customers receive the highest level of support and reliability when ordering from our store
We also offer targeted support through our own line of quick-access supplements, such as GLP-1 Daily Support, which are specifically formulated to complement your journey without the guesswork